-       Clinical Trials 
   - April 2025
    -  40 Pages 
    Global
   
   From       €899EUR$1,000USD£788GBP 
      €1124EUR$1,250USD£985GBP 
                -       Drug Pipelines 
   - June 2025
    -  200 Pages 
    Global
   
   From       €2507EUR$2,789USD£2,198GBP 
                  -       Report 
   - May 2024
    -  129 Pages 
    Global
   
   From       €4965EUR$5,524USD£4,354GBP 
      €5841EUR$6,499USD£5,123GBP 
                -       Drug Pipelines 
   - November 2020
    -  40 Pages 
    Global
   
   From       €1798EUR$2,000USD£1,577GBP 
                  -       Report 
   - June 2024
    -  200 Pages 
    Global
   
   From       €5716EUR$6,360USD£5,013GBP 
      €7146EUR$7,950USD£6,267GBP 
                       Gingivitis is a common form of gum disease caused by the buildup of plaque on the teeth. It is characterized by red, swollen, and bleeding gums. Gingivitis is typically treated with a combination of professional dental cleaning and good oral hygiene. Pharmaceuticals play an important role in the treatment of gingivitis, with a variety of drugs available to help reduce inflammation and prevent further damage to the gums.
Common gingivitis drugs include antibiotics, antiseptics, and anti-inflammatory    medications. Antibiotics are used to reduce the number of bacteria in the mouth, while antiseptics help to reduce inflammation and prevent further infection. Anti-inflammatory medications help to reduce swelling and pain associated with gingivitis.
Some of the companies in the gingivitis drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies produce a variety of drugs to treat gingivitis, including antibiotics, antiseptics, and anti-inflammatory medications. Show Less   Read more